Overview
Dr. Casey Mehrhoff received her Master of Science in Biomedical Sciences and medical degree from Kansas City University of Medicine, completed her Pediatric Residency at Loyola University Medical Center in Chicago, and her Pediatric Hematology/Oncology Fellowship at Ann & Robert H. Lurie Children's Hospital of Chicago. She is currently an Assistant Professor of Pediatrics at the University of Utah within the Division of Pediatric Hematology/Oncology at Primary Children's Hospital. Her clinical focus is on pediatric patients with solid tumor malignancies, with a specific focus on patients diagnosed with rare tumors and patients with cancer predisposition syndromes. She is the co-director and co-founder of the Pediatric Multidisciplinary Thyroid Team and is the co-director and founder of the Pediatric Multidisciplinary Melanoma program and is involved with these specialties on a national level. She is a provider in the high risk genetics cancer predisposition clinic at Huntsman Cancer Institute where she provides care and cancer screening for patients with certain cancer predisposition syndromes, such as Li Fraumeni Syndrome, DICER1, and Familial Adenomatous Polyposis, to name a few. Her research interest is in translational research and clinical trials.
Dr. Mehrhoff is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Acute Lymphoblastic Leukemia (ALL), and Immune Thrombocytopenic Purpura (ITP).
Her clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Neuroblastoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- HMO
- POS
Locations
100 North Mario Capecchi Drive, Suite 1400, Salt Lake City, UT 84113
50 North Medical Drive, Salt Lake City, UT 84132
2250 North Miller Campus Drive, Larry H. And Gail Miller Family Campus, Lehi, UT 84043
Additional Areas of Focus
Dr. Mehrhoff has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Phillip Barnette is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Barnette is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, Leukemia, Hepatoblastoma, and Bone Marrow Aspiration.
Primary Children's Hospital - Hematology Oncology
Dr. Dietz received his degrees in medicine and medical education from the University of New England. He completed his Pediatric Residency and Hematology and Oncology Fellowship at Oregon Health & Science University where he also served as chief resident.In 2020 Dr. Dietz joined the faculty of the University of Utah, where he is currently an Assistant Professor of Pediatrics in the Division of Pediatric Hematology and Oncology. Clinically, Dr. Dietz focuses on the care of pediatric and young adult patients with bone and soft tissue sarcoma, as well as children with retinoblastoma. He is the Associate Director of the Primary Children's Hospital Solid Tumor Program and leads the Comprehensive Retinoblastoma Program. Dr. Dietz is committed to delivering cutting edge clinical care, as well as providing patients with access to experimental therapeutics and discovery programs.�Dr. Dietz's research efforts include team science approaches to better understand the biology driving cancer progression and treatment resistance with a focus on translating this work into new therapies. He is a member of the Huntsman Cancer Institute's Experimental Therapeutics Program and actively involved in the development of early phase clinical trials through multiple cooperative consortia including the Children's Oncology Group, The Sunshine Project, the Pediatric Oncology Experimental Therapeutics Investigator's Consortium, and the Pediatric Early Phase Clinical Trial Network. Dr. Dietz is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Ewing Sarcoma, Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, and Bone Marrow Aspiration.
Primary Children's Hospital - Hematology Oncology
J Dolan is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Dolan has been practicing medicine for over 6 years and is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Hereditary Neuroblastoma, Neuroblastoma, Acute Lymphoblastic Leukemia (ALL), and Immune Thrombocytopenic Purpura (ITP). Dr. Dolan is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Mehrhoff isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Embryonal Tumor with Multilayered RosettesDr. Mehrhoff isExperienced. Learn about Embryonal Tumor with Multilayered Rosettes.
- NeuroblastomaDr. Mehrhoff isExperienced. Learn about Neuroblastoma.